====== Preclinical Animal Study ====== A **preclinical [[animal study]]** is a type of [[scientific research]] conducted prior to initiating [[clinical trial]]s in humans. Its primary aim is to assess the **safety**, **toxicity**, **pharmacokinetics**, and often the **preliminary efficacy** of a proposed medical intervention. ===== ๐Ÿ” Purpose ===== * To determine if a new drug, therapy, or device is **safe** and **potentially effective** before human testing. * To support regulatory submissions (e.g., [[FDA]] IND application). ===== ๐Ÿ Animal Models ===== * Use of animals that **mimic human disease** or relevant physiological conditions. * Common species: mice, rats, rabbits, pigs, non-human primates. * Models must demonstrate: * [[Biological relevance]] * [[Predictive validity]] for human outcomes ===== ๐Ÿ”ฌ Typical Assessments ===== * **Toxicity studies** (acute, subacute, chronic) * **Histopathological evaluation** * **Organ function monitoring** * **Drug absorption, distribution, metabolism, excretion (ADME)** * **Behavioral and neurological testing** (in neuro studies) ===== โš–๏ธ Ethical Considerations ===== * Compliance with ethical standards and animal welfare laws * Implementation of the [[3Rs]]: - **Replacement** (use alternatives when possible) - **Reduction** (minimize number of animals) - **Refinement** (optimize procedures to reduce suffering) ===== ๐Ÿ“‹ Regulatory Importance ===== * Preclinical results are required to: * Define starting dose in human trials * Justify trial design and risk mitigation * Obtain approval for [[first-in-human studies]] ---- ====== Preclinical vs Experimental Animal Study ====== While closely related, **preclinical animal studies** and **experimental animal studies** are not exactly the same. Below is a structured comparison: ^ Feature ^ Preclinical Animal Study ^ Experimental Animal Study ^ | **Definition** | Subset of animal research aimed at clinical translation | Broad category of studies involving animals | | **Primary Purpose** | To evaluate safety, toxicity, pharmacokinetics, and preliminary efficacy before human trials | To explore biological mechanisms, disease models, or test hypotheses | | **Regulatory Context** | Required for regulatory submission (e.g., [[FDA]] IND) | Not necessarily linked to regulatory processes | | **Goal** | Support first-in-human trials | Generate scientific knowledge, may or may not be translational | | **Typical Outputs** | Data for dose selection, risk assessment, trial design | Mechanistic insights, disease modeling, biomarker discovery | | **Examples** | Testing new drug in mice before human trial | Studying gene expression changes in Alzheimerโ€™s mice | | **Field** | Translational / applied research | Basic or applied research | | **Scope** | Narrower: focused on clinical applicability | Broader: includes all types of animal experimentation | ---- **Summary**: * All **preclinical animal studies** are **experimental**, * But not all **experimental animal studies** are **preclinical**. ---- **Tags**: preclinical, experimental, animal studies, translational research, basic science, IND